Anoctamin 1 inhib 
Welcome,         Profile    Billing    Logout  
 2 Companies  1 Product   1 Product   17 Diseases   4 Trials   66 News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mytesi (crofelemer) / Jaguar Health, Knight Therap
NCT03898856: Yield of Diagnostic Tests and Effects of Crofelemer for Chronic Idiopathic Diarrhea In Non-HIV Patients

Recruiting
4
100
US
Crofelemer, Diagnostic tests for cause of chronic diarrhea
The University of Texas Health Science Center, Houston, Napo Pharmaceuticals, Inc.
Chronic Diarrhea of Unknown Origin
10/24
12/24
OnTARGET, NCT04538625: Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy

Completed
3
287
US, RoW
Crofelemer 125 MG [Mytesi], Placebo
Napo Pharmaceuticals, Inc.
Cancer Therapy-Related Diarrhea, Chemotherapy-related Diarrhea, Adult Solid Tumor, Prophylaxis of Diarrhea, Symptomatic Relief of Diarrhea, Targeted Therapy-related Diarrhea
08/23
10/23
NCT06326645: Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome

Not yet recruiting
1
6
US
Crofelemer Oral Product
Lindsey Russell, MD, Napo Pharmaceuticals, Inc.
Short Bowel Syndrome
12/25
12/25
NCT05804396: Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for Preventive Treatment of Migraine

Not yet recruiting
N/A
57
NA
Relivion®
Neurolief Ltd.
Migraine
06/25
06/25
niclosamide (AR-001) / Aeon Respire
No trials found

Download Options